MARKET

SRNE

SRNE

Sorrento Thera
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.43
-0.05
-0.53%
After Hours: 9.54 +0.11 +1.17% 19:59 09/18 EDT
OPEN
9.08
PREV CLOSE
9.48
HIGH
9.46
LOW
8.64
VOLUME
35.17M
TURNOVER
--
52 WEEK HIGH
19.39
52 WEEK LOW
1.390
MARKET CAP
2.41B
P/E (TTM)
-5.8477
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average SRNE stock price target is 24.00 with a high estimate of 30.00 and a low estimate of 21.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SRNE
Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-T), antibody-drug conjugates (ADC), as well as bispecific antibody approaches. Additionally, Sorrento Therapeutics segment also includes Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system to potentially achieve improved efficacy and fewer adverse effects than standard parenteral immunotherapy. The Scilex segment is organized around its non-opioid pain management operations.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Sorrento Therapeutics Inc stock information, including NASDAQ:SRNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRNE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRNE stock methods without spending real money on the virtual paper trading platform.